Y-mAbs Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Y-mAbs Therapeutics, Inc.
CIK #0001722964
EDGAR Form CIK 2011 - 2025
10-K [0001722964]
10-Q [0001722964]
3 [0001722964]
4 [0001722964]
8-K [0001722964]
SC 13D [0001722964]
SC 13G [0001722964]
Form 13D/13G Filer Form 13D/13G Subject Filed
Glazer Capital LLC Y-Mabs Therapeutics Inc [2025-08-15]
Beryl Capital Management LLC Y-Mabs Therapeutics Inc [2025-08-12]
Caligan Partners LP Y-Mabs Therapeutics Inc [2025-05-14]
Paradigm Biocapital Advisors LP Y-Mabs Therapeutics Inc [2024-04-08]
Acorn BioVentures LP Y-Mabs Therapeutics Inc [2023-04-03]
WG Biotech APS Y-Mabs Therapeutics Inc [2023-02-14]
Vanguard Group Inc Y-Mabs Therapeutics Inc [2023-02-09]
BlackRock Inc Y-Mabs Therapeutics Inc [2021-02-02]
Cheung Nai-Kong V Y-Mabs Therapeutics Inc [2020-08-26]
BlackRock Inc Y-Mabs Therapeutics Inc [2020-02-07]
View All
Form 3/4/5 Subject 2011 - 2025
Y-mAbs Therapeutics, Inc.
Hamill Laura
Tyagi ASHU
Wedell-Wedellsborg Johan
Healy James
Gill David N
Gad Thomas
Rossi Michael J
Pfreundschuh Peter P
Gentilcore Douglas J
View All
Terms | Privacy | Guide
tony@aum13f.com